ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Capital Reinvestment Ratio
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥288.83 Million) in capital expenditures (CN¥23.89 Million). Check how tangible is ZhuZhou QianJin Pharmaceutical Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ZhuZhou QianJin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks ZhuZhou QianJin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 24 annual periods. For the full cash flow conversion analysis, see ZhuZhou QianJin Pharmaceutical Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for ZhuZhou QianJin Pharmaceutical Co Ltd from 2002 to 2025. See 600479 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | CN¥480.24 Million | CN¥124.17 Million | ▲ +117.9% |
| 2024 | 0.12x | CN¥398.77 Million | CN¥47.32 Million | ▲ +19.5% |
| 2023 | 0.10x | CN¥443.12 Million | CN¥43.99 Million | ▲ +111.5% |
| 2022 | 0.05x | CN¥733.47 Million | CN¥34.43 Million | ▼ -68.3% |
| 2021 | 0.15x | CN¥485.57 Million | CN¥71.88 Million | ▼ -17.4% |
| 2020 | 0.18x | CN¥542.37 Million | CN¥97.24 Million | ▼ -31.4% |
| 2019 | 0.26x | CN¥155.49 Million | CN¥40.61 Million | ▲ +115.9% |
| 2018 | 0.12x | CN¥383.47 Million | CN¥46.39 Million | ▼ -40.2% |
| 2017 | 0.20x | CN¥283.47 Million | CN¥57.30 Million | ▼ -65.1% |
| 2016 | 0.58x | CN¥140.88 Million | CN¥81.50 Million | ▼ -53.8% |
| 2015 | 1.25x | CN¥67.48 Million | CN¥84.47 Million | ▲ +247.9% |
| 2014 | 0.36x | CN¥183.34 Million | CN¥65.97 Million | ▼ -41.2% |
| 2013 | 0.61x | CN¥137.63 Million | CN¥84.26 Million | ▼ -52.7% |
| 2012 | 1.30x | CN¥197.82 Million | CN¥256.26 Million | ▼ -54.2% |
| 2011 | 2.83x | CN¥22.58 Million | CN¥63.87 Million | ▲ +89.4% |
| 2010 | 1.49x | CN¥39.13 Million | CN¥58.44 Million | ▼ -10.9% |
| 2009 | 1.68x | CN¥73.54 Million | CN¥123.31 Million | ▼ -34.5% |
| 2008 | 2.56x | CN¥37.20 Million | CN¥95.30 Million | ▲ +801.0% |
| 2007 | 0.28x | CN¥79.26 Million | CN¥22.53 Million | ▲ +59.7% |
| 2006 | 0.18x | CN¥120.12 Million | CN¥21.39 Million | ▼ -18.6% |
| 2005 | 0.22x | CN¥76.50 Million | CN¥16.74 Million | ▼ -92.9% |
| 2004 | 3.06x | CN¥18.45 Million | CN¥56.50 Million | ▲ +358.2% |
| 2003 | 0.67x | CN¥50.96 Million | CN¥34.05 Million | ▼ -93.1% |
| 2002 | 9.75x | CN¥6.07 Million | CN¥59.24 Million | — |